Recent reports confirm that the management of chronic anal fissure has undergone extensive re-evaluation during the past few years. This rejuvenation of interest is attributable to the application of neurochemical treatment, which has contributed to the tendency to treat the disease on an outpatient basis. The use of botulinum neurotoxin seems to be a promising and safe approach for the treatment of chronic anal fissure, particularly in patients at high risk for incontinence. Indeed, botulinum neurotoxin has been successfully used selectively to weaken the internal anal sphincter as a treatment for chronic anal fissure. It is also more efficacious than nitrate therapy, and is not related to the patient's willingness to complete treatment.

Brisinda, G., Cadeddu, F., Brandara, F., Brisinda, D., Maria, G., Treating chronic anal fissure with botulinum neurotoxin, <<NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY>>, 2004; 1 (2): 82-89. [doi:10.1038/ncpgasthep0048] [http://hdl.handle.net/10807/207760]

Treating chronic anal fissure with botulinum neurotoxin

Brisinda, G.
;
Cadeddu, F.;Brisinda, D.;
2004

Abstract

Recent reports confirm that the management of chronic anal fissure has undergone extensive re-evaluation during the past few years. This rejuvenation of interest is attributable to the application of neurochemical treatment, which has contributed to the tendency to treat the disease on an outpatient basis. The use of botulinum neurotoxin seems to be a promising and safe approach for the treatment of chronic anal fissure, particularly in patients at high risk for incontinence. Indeed, botulinum neurotoxin has been successfully used selectively to weaken the internal anal sphincter as a treatment for chronic anal fissure. It is also more efficacious than nitrate therapy, and is not related to the patient's willingness to complete treatment.
Inglese
Brisinda, G., Cadeddu, F., Brandara, F., Brisinda, D., Maria, G., Treating chronic anal fissure with botulinum neurotoxin, <<NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY>>, 2004; 1 (2): 82-89. [doi:10.1038/ncpgasthep0048] [http://hdl.handle.net/10807/207760]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/207760
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 21
social impact